RAPT Therapeutics
RAPT
RAPT
96 hedge funds and large institutions have $578M invested in RAPT Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $637M → $578M (-$59M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
96
Holding in Top 10
4
Calls
$9.89M
Puts
$209K
Top Buyers
| 1 | +$10.1M | |
| 2 | +$7.7M | |
| 3 | +$6.3M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$5.65M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.65M |
Top Sellers
| 1 | -$7.51M | |
| 2 | -$6.03M | |
| 3 | -$5.57M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$3.96M |
| 5 |
Morgan Stanley
New York
|
-$2.72M |